MXPA04009535A - Terapia con estatina para mejorar el mantenimiento cognoscitivo. - Google Patents
Terapia con estatina para mejorar el mantenimiento cognoscitivo.Info
- Publication number
- MXPA04009535A MXPA04009535A MXPA04009535A MXPA04009535A MXPA04009535A MX PA04009535 A MXPA04009535 A MX PA04009535A MX PA04009535 A MXPA04009535 A MX PA04009535A MX PA04009535 A MXPA04009535 A MX PA04009535A MX PA04009535 A MXPA04009535 A MX PA04009535A
- Authority
- MX
- Mexico
- Prior art keywords
- statin
- statin therapy
- enhancing cognitive
- galantamine
- active ingredient
- Prior art date
Links
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title abstract 3
- 230000001149 cognitive effect Effects 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 title 1
- 238000012423 maintenance Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 abstract 4
- 206010012289 Dementia Diseases 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 229960003980 galantamine Drugs 0.000 abstract 2
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000026139 Memory disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36928502P | 2002-04-02 | 2002-04-02 | |
| PCT/EP2003/003324 WO2003082298A1 (en) | 2002-04-02 | 2003-03-28 | Statin therapy for enhancing cognitive maintenance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04009535A true MXPA04009535A (es) | 2005-01-25 |
Family
ID=28675573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04009535A MXPA04009535A (es) | 2002-04-02 | 2003-03-28 | Terapia con estatina para mejorar el mantenimiento cognoscitivo. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1492539B1 (https=) |
| JP (1) | JP2005525391A (https=) |
| KR (1) | KR100986194B1 (https=) |
| CN (1) | CN100528164C (https=) |
| AT (1) | ATE331523T1 (https=) |
| AU (1) | AU2003226753B2 (https=) |
| BR (1) | BR0308293A (https=) |
| CA (1) | CA2480275C (https=) |
| CY (1) | CY1105545T1 (https=) |
| DE (1) | DE60306503T2 (https=) |
| DK (1) | DK1492539T3 (https=) |
| EA (1) | EA013069B1 (https=) |
| ES (1) | ES2268393T3 (https=) |
| IL (2) | IL164317A0 (https=) |
| MX (1) | MXPA04009535A (https=) |
| NO (1) | NO20044698L (https=) |
| NZ (1) | NZ536111A (https=) |
| PL (1) | PL211160B1 (https=) |
| PT (1) | PT1492539E (https=) |
| UA (1) | UA79605C2 (https=) |
| WO (1) | WO2003082298A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004071431A2 (en) * | 2003-02-05 | 2004-08-26 | Myriad Genetics, Inc. | Method and composition for treating neurodegenerative disorders |
| CN1960781A (zh) * | 2004-04-14 | 2007-05-09 | 沃尼尔·朗伯有限责任公司 | 治疗阿尔茨海默氏病的治疗组合 |
| JP2005350471A (ja) * | 2004-06-08 | 2005-12-22 | Axonyx Inc | β−アミロイド前駆体タンパク質阻害剤およびＨＭＧＣｏＡ還元酵素阻害剤を使用するアルツハイマー病の進行を遅延させる方法 |
| GB0607946D0 (en) * | 2006-04-21 | 2006-05-31 | Minster Res The Ltd | Mono and combination therapy |
| EP2076288A2 (en) * | 2006-09-22 | 2009-07-08 | Braincells, Inc. | Combination comprising an hmg-coa reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis |
| TWI432195B (zh) | 2007-10-03 | 2014-04-01 | Kowa Co | 神經細胞死亡抑制劑 |
| US20160303146A1 (en) * | 2013-12-13 | 2016-10-20 | David A. TABACZYNSKI | Inhibition of isoprenoid biosynthetic pathways to treat neuroinflammatory disorders |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW506836B (en) * | 1996-06-14 | 2002-10-21 | Janssen Pharmaceutica Nv | Fast-dissolving galanthamine hydrobromide tablet |
-
2003
- 2003-03-28 MX MXPA04009535A patent/MXPA04009535A/es active IP Right Grant
- 2003-03-28 KR KR1020047013127A patent/KR100986194B1/ko not_active Expired - Fee Related
- 2003-03-28 EP EP03745196A patent/EP1492539B1/en not_active Expired - Lifetime
- 2003-03-28 NZ NZ536111A patent/NZ536111A/xx not_active IP Right Cessation
- 2003-03-28 AT AT03745196T patent/ATE331523T1/de active
- 2003-03-28 DE DE60306503T patent/DE60306503T2/de not_active Expired - Lifetime
- 2003-03-28 AU AU2003226753A patent/AU2003226753B2/en not_active Ceased
- 2003-03-28 ES ES03745196T patent/ES2268393T3/es not_active Expired - Lifetime
- 2003-03-28 CA CA2480275A patent/CA2480275C/en not_active Expired - Fee Related
- 2003-03-28 WO PCT/EP2003/003324 patent/WO2003082298A1/en not_active Ceased
- 2003-03-28 JP JP2003579835A patent/JP2005525391A/ja active Pending
- 2003-03-28 PL PL371551A patent/PL211160B1/pl unknown
- 2003-03-28 EA EA200401295A patent/EA013069B1/ru not_active IP Right Cessation
- 2003-03-28 IL IL16431703A patent/IL164317A0/xx unknown
- 2003-03-28 BR BR0308293-8A patent/BR0308293A/pt not_active IP Right Cessation
- 2003-03-28 CN CNB038073854A patent/CN100528164C/zh not_active Expired - Fee Related
- 2003-03-28 PT PT03745196T patent/PT1492539E/pt unknown
- 2003-03-28 DK DK03745196T patent/DK1492539T3/da active
- 2003-03-28 UA UA20040806803A patent/UA79605C2/uk unknown
-
2004
- 2004-09-28 IL IL164317A patent/IL164317A/en not_active IP Right Cessation
- 2004-10-29 NO NO20044698A patent/NO20044698L/no not_active Application Discontinuation
-
2006
- 2006-09-27 CY CY20061101397T patent/CY1105545T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN100528164C (zh) | 2009-08-19 |
| ATE331523T1 (de) | 2006-07-15 |
| AU2003226753A1 (en) | 2003-10-13 |
| NO20044698L (no) | 2004-10-29 |
| DE60306503T2 (de) | 2007-06-21 |
| IL164317A (en) | 2010-04-29 |
| NZ536111A (en) | 2006-03-31 |
| IL164317A0 (en) | 2005-12-18 |
| CA2480275C (en) | 2011-08-16 |
| DE60306503D1 (de) | 2006-08-10 |
| CY1105545T1 (el) | 2010-07-28 |
| WO2003082298A1 (en) | 2003-10-09 |
| HK1079688A1 (zh) | 2006-04-13 |
| ES2268393T3 (es) | 2007-03-16 |
| PL211160B1 (pl) | 2012-04-30 |
| BR0308293A (pt) | 2004-12-28 |
| CN1642555A (zh) | 2005-07-20 |
| UA79605C2 (en) | 2007-07-10 |
| DK1492539T3 (da) | 2006-10-30 |
| AU2003226753B2 (en) | 2007-06-28 |
| CA2480275A1 (en) | 2003-10-09 |
| PL371551A1 (en) | 2005-06-27 |
| EP1492539A1 (en) | 2005-01-05 |
| JP2005525391A (ja) | 2005-08-25 |
| KR100986194B1 (ko) | 2010-10-07 |
| KR20040096608A (ko) | 2004-11-16 |
| EP1492539B1 (en) | 2006-06-28 |
| EA013069B1 (ru) | 2010-02-26 |
| EA200401295A1 (ru) | 2005-02-24 |
| PT1492539E (pt) | 2006-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60126980D1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| MXPA05006940A (es) | Formulaciones terapeuticas para el tratamiento de enfermedades relacionadas con beta - amiloide. | |
| DE69713526D1 (de) | Lösliche prodrugs von paclitaxel | |
| PL309604A1 (en) | Pharmaceutical composition for treating nicotin dependence | |
| MXPA05003253A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos. | |
| MY118526A (en) | Method for improving the pharmacokinetics of tipranavir | |
| ATE273693T1 (de) | Proteinhaltige arzneimittel | |
| UA32457C2 (uk) | Лікарський засіб (варіанти) і спосіб медикаментозного впливу на організм | |
| BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
| IL164317A0 (en) | Statin therapy for enhancing cognitive maintenance | |
| GB2331926A (en) | Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine | |
| BG105342A (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases | |
| TW200633694A (en) | Composition and method for treating asthma | |
| GEP20053512B (en) | S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders. | |
| TW200700075A (en) | Roflumilast and integrin inhibitor combination and method of treatment | |
| ATE293445T1 (de) | Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel | |
| NZ268914A (en) | Use of efaroxan and derivatives to prepare medicaments for treating neurodegenerative diseases especially alzheimer's disease | |
| DE69434002D1 (de) | 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis | |
| UA41326C2 (uk) | Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань | |
| WO2003066806A3 (en) | Therapeutic use of aziridino compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |